U.S. Markets closed

Arcadia Biosciences, Inc. (RKDA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
3.0100-0.4400 (-12.75%)
At close: 4:00PM EST

3.0400 +0.03 (1.00%)
After hours: 4:35PM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close3.4500
Open3.0000
Bid2.9700 x 21500
Ask2.9700 x 4000
Day's Range2.9100 - 3.0500
52 Week Range2.3000 - 6.4800
Volume3,287,961
Avg. Volume380,339
Market Cap40.487M
Beta (5Y Monthly)-0.63
PE Ratio (TTM)N/A
EPS (TTM)-2.1230
Earnings DateNov 12, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.67
  • Arcadia Biosciences (RKDA) Announces $25.1 Million Private Placement
    PR Newswire

    Arcadia Biosciences (RKDA) Announces $25.1 Million Private Placement

    Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced that it has entered into definitive agreements with several institutional and other accredited investors for the purchase of 7,876,784 shares of its common stock at a purchase price per share of $3.1925, in a private placement priced at-the-market under Nasdaq rules. Additionally, Arcadia has also agreed to issue to the investors warrants to purchase up to 3,938,392 shares of common stock. The warrants to purchase 3,938,392 shares of common stock have an exercise price of $3.13 per share, will be immediately exercisable and will expire five and one-half years from the issue date. The closing of the offering is expected to occur on or about January 27, 2021, subject to the satisfaction of customary closing conditions.

  • Arcadia Biosciences (RKDA) Announces Closing of $8.0 Million Registered Direct Offering Priced At-the-Market
    PR Newswire

    Arcadia Biosciences (RKDA) Announces Closing of $8.0 Million Registered Direct Offering Priced At-the-Market

    Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced the closing of its previously announced registered direct offering of 2,618,658 shares of its common stock. The offering was priced at-the-market at a purchase price per share of $2.93, for gross proceeds of approximately $7.7 million. Additionally, in a concurrent private placement, Arcadia issued unregistered warrants to purchase up to 2,618,658 shares of common stock, representing 100 percent of the shares of common stock purchased in the registered direct offering. Each warrant was sold at a price of $0.125 per underlying warrant share for gross proceeds of approximately $327,000. Each warrant has an exercise price of $3.00 per share, is exercisable immediately and will expire five and one-half years from the issuance date.

  • Arcadia Biosciences (RKDA) Announces $8.0 Million Registered Direct Offering Priced At-the-Market
    PR Newswire

    Arcadia Biosciences (RKDA) Announces $8.0 Million Registered Direct Offering Priced At-the-Market

    Arcadia Biosciences, Inc.® (Nasdaq: RKDA), a leader in science-based approaches to enhancing the quality and nutritional value of crops and food ingredients, today announced that it has entered into definitive agreements with several institutional and other accredited investors for the purchase of 2,618,658 shares of its common stock, at a purchase price per share of $3.055, in a registered direct offering priced at-the-market under Nasdaq rules. Additionally, Arcadia has also agreed to issue to the investors unregistered warrants to purchase up to 2,618,658 shares of common stock. The closing of the offering is expected to occur on or about December 22, 2020, subject to the satisfaction of customary closing conditions.